CMO (Cerasomol-cis-9-Cetyl Myristoleate) in the Treatment of Fibromyalgia: An Open Pilot Study

Author: Edwards A. M.  

Publisher: Informa Healthcare

ISSN: 1364-6907

Source: Journal of Nutritional & Environmental Medicine, Vol.11, Iss.2, 2001-06, pp. : 105-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract